{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T17:24:33Z","timestamp":1763400273436,"version":"3.45.0"},"reference-count":12,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jcehepatology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical and Experimental Hepatology"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.jceh.2025.103188","type":"journal-article","created":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T23:47:10Z","timestamp":1758152830000},"page":"103188","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["The Interaction of Human Factors and Resistance-associated Substitutions in Hepatitis C Elimination"],"prefix":"10.1016","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7031-496X","authenticated-orcid":false,"given":"Judah","family":"Kupferman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8234-4485","authenticated-orcid":false,"given":"Paul Y.","family":"Kwo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jceh.2025.103188_bib1","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a036913","article-title":"Hepatitis C virus epidemiology and the impact of interferon-free hepatitis C virus therapy","volume":"10","author":"Lazarus","year":"2020","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.1016\/j.jceh.2025.103188_bib2","doi-asserted-by":"crossref","first-page":"2444","DOI":"10.1056\/NEJMct061675","article-title":"Peginterferon and ribavirin for chronic hepatitis C.","volume":"355","author":"Hoofnagle","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jceh.2025.103188_bib3","first-page":"10","article-title":"APASL consensus statements and recommendation on treatment of hepatitis C","author":"Omata","year":"2016","journal-title":"Hepatol Int"},{"key":"10.1016\/j.jceh.2025.103188_bib4","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/S2468-1253(21)00267-3","article-title":"New WHO guidance for country validation of viral hepatitis B and C elimination","volume":"6","author":"Easterbrook","year":"2021","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2025.103188_bib5","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S2468-1253(25)00068-8","article-title":"A 2024 global report on national policies, programmes, and progress towards hepatitis C elimination: findings from 33 hepatitis elimination profiles","volume":"10","author":"Hiebert-Suwondo","year":"2025","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2025.103188_bib6","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.45424","article-title":"Characteristics and treatment rate of patients with hepatitis C virus infection in the direct-acting antiviral era and during the COVID-19 pandemic in the United States","volume":"5","author":"Nguyen","year":"2022","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.jceh.2025.103188_bib7","first-page":"1755","article-title":"National viral hepatitis control program in India: call for update","author":"Pandey","year":"2023","journal-title":"Medknow"},{"key":"10.1016\/j.jceh.2025.103188_bib8","doi-asserted-by":"crossref","first-page":"321","DOI":"10.25259\/IJMR_743_2025","article-title":"Fast pacing India's fight against viral hepatitis: targets & action points","volume":"161","author":"Gupta","year":"2025","journal-title":"Indian J Med Res"},{"key":"10.1016\/j.jceh.2025.103188_bib9","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3390\/v13102096","article-title":"The role of RASs\/RVs in the current management of HCV","volume":"13","author":"Malandris","year":"2021","journal-title":"Viruses"},{"key":"10.1016\/j.jceh.2025.103188_bib10","doi-asserted-by":"crossref","first-page":"102601","DOI":"10.1016\/j.jceh.2025.102601","article-title":"Impact of resistance associated substitutions and predictors of treatment failure following direct-acting antiviral therapy in a viral hepatitis C elimination cohort","volume":"15","author":"Premkumar","year":"2025","journal-title":"J Clin Exp Hepatol"},{"key":"10.1016\/j.jceh.2025.103188_bib11","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1016\/j.cgh.2019.10.046","article-title":"World-wide prevalence of substitutions in HCV genome associated with resistance to direct-acting antiviral agents","volume":"19","author":"Liu","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2025.103188_bib12","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/j.jhep.2019.07.006","article-title":"Decentralized care with generic direct-acting antivirals in the management of chronic hepatitis C in a public health care setting","volume":"71","author":"Dhiman","year":"2019","journal-title":"J Hepatol"}],"container-title":["Journal of Clinical and Experimental Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0973688325006887?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0973688325006887?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T17:14:00Z","timestamp":1763399640000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0973688325006887"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":12,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S0973688325006887"],"URL":"https:\/\/doi.org\/10.1016\/j.jceh.2025.103188","relation":{},"ISSN":["0973-6883"],"issn-type":[{"type":"print","value":"0973-6883"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Interaction of Human Factors and Resistance-associated Substitutions in Hepatitis C Elimination","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical and Experimental Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jceh.2025.103188","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Indian National Association for Study of the Liver. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"103188"}}